TY - JOUR
T1 - Modulatory effect of some steroid hormones, their glucuronides and ouabain-like compounds on Cavia cobaya kidney Na+,K+-ATPase activity
AU - Giunta, C.
AU - Ferrero, P.
AU - Pizzuto, M.
AU - Cavaletto, M.
AU - Pessione, E.
AU - Bracchino, P.
N1 - Funding Information:
Acknowledgements--This work was supported by a grant from the Italian Ministero della Pubblica Istruzione (40%) and from the Regione Piemonte (Ricerca Sanitaria Finaliz-zata, 77/83). Very many thanks to the "Cassa di Risparmio della provincia di Torino'" for the supply of the DU 70 Beckman spectrophotometer.
PY - 1990
Y1 - 1990
N2 - 1. Ouabain-like compounds (approx. mol. wt 700, 2,000 and 4,000 Da) were purified from plasma of essential hypertensive patients. 2. Dose-response experiments performed with (a) steroid hormones, (b) their glucuronides and (c) ouabain-like compounds, emphasize a modulatory effect [activation of the Na,K-ATPase at very low concentrations of ligand, inhibition at higher levels; apparent Ki: (a) between 1 and 0.5 mM; (b) between 1 and 0.5 μM; and (c) between 10 and 1 nM; maximum enhancement of the enzymatic activity: (a) + 20%; (b) + 45%; and (c) + 100%]. 3. Displacement experiments of [3H]ouabain evidence a high competition of the ligands towards the cardioglycoside. The relative I50s are: (a) between 1 and 0.5 mM; (b) between 10 and 1 μM; and (c) between 10 and 0.01 nM.
AB - 1. Ouabain-like compounds (approx. mol. wt 700, 2,000 and 4,000 Da) were purified from plasma of essential hypertensive patients. 2. Dose-response experiments performed with (a) steroid hormones, (b) their glucuronides and (c) ouabain-like compounds, emphasize a modulatory effect [activation of the Na,K-ATPase at very low concentrations of ligand, inhibition at higher levels; apparent Ki: (a) between 1 and 0.5 mM; (b) between 1 and 0.5 μM; and (c) between 10 and 1 nM; maximum enhancement of the enzymatic activity: (a) + 20%; (b) + 45%; and (c) + 100%]. 3. Displacement experiments of [3H]ouabain evidence a high competition of the ligands towards the cardioglycoside. The relative I50s are: (a) between 1 and 0.5 mM; (b) between 10 and 1 μM; and (c) between 10 and 0.01 nM.
UR - http://www.scopus.com/inward/record.url?scp=0025334873&partnerID=8YFLogxK
U2 - 10.1016/0306-3623(90)90694-H
DO - 10.1016/0306-3623(90)90694-H
M3 - Article
SN - 0306-3623
VL - 21
SP - 435
EP - 442
JO - Vascular Pharmacology
JF - Vascular Pharmacology
IS - 4
ER -